02/10/2025
9:25 AM | Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:06 AM | Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:23 AM | Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/30/2025
8:33 PM | Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/29/2025
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/14/2025
4:02 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:34 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for CRNX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/18/2024
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:32 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
7:07 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:06 PM | Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:55 PM | Crinetics Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
1:26 PM | Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/04/2024
10:20 AM | Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/17/2024
11:47 AM | Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
3:08 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:13 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
10/08/2024
4:01 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
10/07/2024
6:55 AM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:01 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2024
3:23 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:06 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
11:11 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:31 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
12:16 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
10:35 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
3:38 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:04 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
9:54 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
4:35 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:14 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:38 PM | Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
07/15/2024
3:28 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
9:28 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
5:04 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:10 PM | Crinetics Pharmaceuticals (Subject)
Hassard James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
12:07 PM | Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
3:32 PM | Crinetics Pharmaceuticals (Issuer)
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:31 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:32 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:03 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
10:01 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
5:07 PM | Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
4:08 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:24 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:45 PM | Crinetics Pharmaceuticals (Filer)
| Form S-3ASR | |
06/21/2024
3:31 PM | Crinetics Pharmaceuticals (Subject)
Hassard James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
3:35 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:30 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
10:55 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
12:44 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
7:23 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
5:29 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
3:47 PM | Crinetics Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:48 PM | Crinetics Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:50 PM | Crinetics Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
4:23 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:36 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:09 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:52 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
3:17 PM | Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:31 PM | Crinetics Pharmaceuticals (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
1:34 PM | Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
4:20 PM | Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
5:31 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:32 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:33 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:34 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:35 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:36 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:37 PM | Crinetics Pharmaceuticals (Subject)
Fust Matthew K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:40 PM | Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
5:31 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
3:15 PM | Crinetics Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/11/2024
2:34 PM | Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
03/06/2024
7:18 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:59 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
03/06/2024
7:00 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:01 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:01 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:57 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:05 PM | Crinetics Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/01/2024
3:41 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 POS | |
02/28/2024
3:31 PM | Crinetics Pharmaceuticals (Subject)
Krasner Alan Seth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
